The rise of telehealth has brought about significant changes in the way healthcare is delivered, with more and more people opting for virtual consultations and prescriptions. However, a recent analysis by STAT’s Katie Palmer sheds light on the role of medical groups in this telehealth revolution. While the FDA has been cracking down on telehealth companies for their marketing practices, it’s important to note that these companies do not directly prescribe medications. Instead, doctors affiliated with medical groups are the ones prescribing these medications. In fact, Katie found that a small number of medical groups provide doctors to a large number of telehealth companies, with at least 30% of the companies warned by the FDA having affiliations with just four nationwide medical groups. As awareness grows around this complex model of direct-to-consumer prescribing, there could be long-lasting implications for both patients and prescribers.
In other health news, a recent study published in Nature Medicine highlights the long-term impact of oral antibiotics on the gut microbiome. The study, which involved nearly 15,000 people in Sweden, found that a course of antibiotics could affect the composition of the gut microbiome for up to 8 years. Specific antibiotics like clindamycin, fluoroquinolones, and flucloxacillin had the strongest associations with reduced gut microbiome diversity. This research underscores the importance of judicious antibiotic use and the need for more longitudinal data on the subject.
Meanwhile, whistleblower Jenna Norton, a former program officer at the NIH, has been vocal about the challenges faced by scientists under the Trump administration. Despite facing backlash and being put on administrative leave, Norton stands by her decision to speak out against the administration’s actions. She believes that scientists should not shy away from politics and should continue to advocate for evidence-based policies.
On the legislative front, momentum is building for the establishment of an office of men’s health at the federal health department. Lawmakers have been introducing bills for this office for the past 25 years, and the latest bill has bipartisan support. With endorsements from the American Medical Association and a focus on men’s health as part of the MAHA agenda, there is hope that this initiative could help improve men’s health outcomes.
Lastly, the American Association of Neurology has released guidance for neurologists on the use of wearable devices to monitor health and vital signs. As wearable technology becomes more prevalent, the guidance highlights the potential benefits of using these devices to gather patient data. While there is limited evidence on the applicability of device data in neurology, the guidance emphasizes the importance of leveraging wearables to enhance patient care.
Overall, these developments in telehealth, gut microbiome research, whistleblower advocacy, men’s health initiatives, and neurology guidance all point to the evolving landscape of healthcare and the need for innovative approaches to improve patient outcomes.
